| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D D Miller, P J Perry, R J Cadoret, N C Andrease. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Comprehensive psychiatry. vol 35. issue 1. 1994-05-06. PMID:8149734. |
clozapine has proven to be more effective than typical antipsychotics in treatment-refractory schizophrenic patients, and some evidence suggests that it may be particularly useful in treating the negative symptoms of schizophrenia. |
1994-05-06 |
2023-08-12 |
Not clear |
| D D Miller, P J Perry, R J Cadoret, N C Andrease. Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Comprehensive psychiatry. vol 35. issue 1. 1994-05-06. PMID:8149734. |
it appears that at least a portion of clozapine's effect on core negative symptoms is mediated through a direct effect on the underlying pathophysiology of schizophrenia associated with negative symptoms. |
1994-05-06 |
2023-08-12 |
Not clear |
| T Mozes, P Toren, N Chernauzan, R Mester, R Yoran-Hegesh, R Blumensohn, A Weizma. Clozapine treatment in very early onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry. vol 33. issue 1. 1994-04-25. PMID:8138523. |
clozapine treatment in very early onset schizophrenia. |
1994-04-25 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, D Irish, W T Carpente. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hospital & community psychiatry. vol 44. issue 12. 1994-04-20. PMID:8132186. |
clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. |
1994-04-20 |
2023-08-12 |
Not clear |
| K Worm, B Kringsholm, A Steentof. Clozapine cases with fatal, toxic or therapeutic concentrations. International journal of legal medicine. vol 106. issue 3. 1994-04-01. PMID:8117587. |
the neuroleptic drug clozapine is used in the treatment of schizophrenia and is characterized by not having the extrapyramidal side-effects usually shown by neuroleptics. |
1994-04-01 |
2023-08-12 |
Not clear |
| M Hasegawa, R Gutierrez-Esteinou, L Way, H Y Meltze. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Journal of clinical psychopharmacology. vol 13. issue 6. 1994-04-01. PMID:8120151. |
relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. |
1994-04-01 |
2023-08-12 |
Not clear |
| P Buckley, P Thompson, L Way, H Y Meltze. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. The American journal of psychiatry. vol 151. issue 3. 1994-03-24. PMID:8109646. |
substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. |
1994-03-24 |
2023-08-12 |
Not clear |
| P Buckley, P Thompson, L Way, H Y Meltze. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. The American journal of psychiatry. vol 151. issue 3. 1994-03-24. PMID:8109646. |
the goals of this study were 1) to determine the extent of substance abuse in patients with treatment-resistant schizophrenia and 2) to assess the relevance of such abuse to subsequent response to treatment with clozapine. |
1994-03-24 |
2023-08-12 |
Not clear |
| D Pickar, R E Litman, W W Hong, T P Su, E M Weissman, J K Hsiao, W Z Potte. Clinical response to clozapine in patients with schizophrenia. Archives of general psychiatry. vol 51. issue 2. 1994-03-03. PMID:8297214. |
clinical response to clozapine in patients with schizophrenia. |
1994-03-03 |
2023-08-12 |
Not clear |
| P Backlar, B H McFarlan. Clozapine rationing in a state mental hospital: reviewing a HEC's case consultation. HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues. vol 5. issue 5. 1994-02-24. PMID:10130976. |
in a three hundred bed state mental hospital that is allotted thirty clozapine slots (high costs effectively rationing this drug), a woman with schizophrenia responds minimally to this medication. |
1994-02-24 |
2023-08-12 |
Not clear |
| A Breier, B Kirkpatrick, R W Buchana. Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia. Biological psychiatry. vol 34. issue 7. 1994-02-03. PMID:8268334. |
clozapine attenuates meta-chlorophenylpiperazine (mcpp)-induced plasma cortisol increases in schizophrenia. |
1994-02-03 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, B Kirkpatrick, O R Davis, D Irish, A Summerfelt, W T Carpente. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. The American journal of psychiatry. vol 151. issue 1. 1994-01-27. PMID:8267129. |
effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. |
1994-01-27 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, B Kirkpatrick, O R Davis, D Irish, A Summerfelt, W T Carpente. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. The American journal of psychiatry. vol 151. issue 1. 1994-01-27. PMID:8267129. |
clozapine is an atypical neuroleptic with superior efficacy in severely ill, treatment-resistant inpatients with schizophrenia. |
1994-01-27 |
2023-08-12 |
Not clear |
| A Breier, R W Buchanan, B Kirkpatrick, O R Davis, D Irish, A Summerfelt, W T Carpente. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. The American journal of psychiatry. vol 151. issue 1. 1994-01-27. PMID:8267129. |
to determine if clozapine's differential efficacy generalizes to less ill, outpatients populations, the authors examined the effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. |
1994-01-27 |
2023-08-12 |
Not clear |
| J M Zito, J Volavka, T J Craig, P Czobor, S Banks, J Vitra. Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia. The Annals of pharmacotherapy. vol 27. issue 10. 1994-01-07. PMID:8251696. |
pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia. |
1994-01-07 |
2023-08-12 |
Not clear |
| J M Zito, J Volavka, T J Craig, P Czobor, S Banks, J Vitra. Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia. The Annals of pharmacotherapy. vol 27. issue 10. 1994-01-07. PMID:8251696. |
to evaluate clozapine in a field trial for hospitalized patients with treatment-resistant schizophrenia. |
1994-01-07 |
2023-08-12 |
Not clear |
| U Meise, M Kurz, W W Fleischhacke. [Clozapine in long-term treatment of schizophrenic patients]. Fortschritte der Neurologie-Psychiatrie. vol 61. issue 9. 1993-12-01. PMID:8225153. |
clozapine has advantages over standard antipsychotics in refractory schizophrenia. |
1993-12-01 |
2023-08-12 |
Not clear |
| U Meise, M Kurz, W W Fleischhacke. [Clozapine in long-term treatment of schizophrenic patients]. Fortschritte der Neurologie-Psychiatrie. vol 61. issue 9. 1993-12-01. PMID:8225153. |
despite this fact clozapine ranked second in a survey dealing with the preference of this antipsychotic in the long-term treatment of schizophrenia. |
1993-12-01 |
2023-08-12 |
Not clear |
| H Y Meltzer, P Cola, L Way, P A Thompson, B Bastani, M A Davies, B Snit. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. The American journal of psychiatry. vol 150. issue 11. 1993-11-16. PMID:8105705. |
cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. |
1993-11-16 |
2023-08-12 |
Not clear |
| H Y Meltzer, P Cola, L Way, P A Thompson, B Bastani, M A Davies, B Snit. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. The American journal of psychiatry. vol 150. issue 11. 1993-11-16. PMID:8105705. |
the goal of this study was to determine whether clozapine is a cost-effective treatment for treatment-resistant schizophrenia. |
1993-11-16 |
2023-08-12 |
Not clear |